AzTrials
AzTrials

Heat ExposureNCT06584903

Safe Indoor Temperature Limit for Fans

A study testing Temperature Ramp Protocol in people with Heat Exposure and Healthy, run by Lakehead University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Extreme heat events are a significant global threat to health and wellbeing, and result in more morbidity and mortality than all other natural disasters combined. Thus, a key priority is identifying effective and accessible heat resilience solutions to protect individuals from the potentially fatal consequences of… Read more about this study

Who is it for?
Ages 19 to 39 yearsHealthy volunteers can take part
Conditions the study is for
Heat Exposure, Healthy, Young Adults
What is being tested?
Temperature Ramp Protocol
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
1 siteCanada
Study dates
20 Jan 2024to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Body mass index less than 30
  • male or female
  • ability to tolerate hot environments for a prolonged period (e.g. \>2 h)

Who cannot join

  • Any respiratory disease
  • Any cardiovascular disease, including hypertension
  • Diabetes
  • not currently on any medication (except oral contraceptives)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Lakehead University

    Thunder Bay, Ontario, P7B 5E1

Other trials in Canada

About this study

Official title: Fan Use During Extreme Heat: Safe Thermal Limits

Extreme heat events are a significant global threat to health and wellbeing, and result in more morbidity and mortality than all other natural disasters combined. Thus, a key priority is identifying effective and accessible heat resilience solutions to protect individuals from the potentially fatal consequences of heat stress. Within a range of ambient conditions, a fan has been recognized a low-cost heat resilience solution. However, when ambient temperatures exceed skin temperatures (e.g., above 35°C), a fan will incur greater dry heat gain which may be counterbalanced with evaporation of sweat from the skin surface. However, at a critical indoor temperature, the rate of heat gain will exceed the rate of evaporation resulting in net heat gain. The critical indoor temperature has yet to be determined. The purpose of this present study is to identify the indoor temperature at which a fan results in greater cardiovascular and thermal strain relative to still air in young adults using a simulated heat wave scenario of a warming room.

Being tested
Temperature Ramp Protocol
Keywords
indoor temperature, core temperature, heart rate, electric fans, cardiovascular strain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Temperature Ramp ProtocolOther

    Following a 45 minute baseline in 37°C seated on a chair, the indoor temperature in the climate-controlled room increased from 37°C to 47°C at ~0.06°C/min (relative humidity ~26%) over 180 minutes.

Study groups in NCT06584903
Study groupRoleWhat they receive
Still airPlacebo comparatorstill air condition with no supplemental air flow
Receives: Other: Temperature Ramp Protocol
Electric fanExperimentalForce air flow with a 46 cm 3-blade fan positioned 1.2 m anterior to the participants chest
Receives: Other: Temperature Ramp Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood Pressure

    Measured with an electrocardiogram-gated automated cuff

    Measured: At baseline (e.g. 0 minutes), and every 10 minutes of exposure up to 180 minutes

  2. Rate Pressure Product

    Measured: At baseline (e.g. 0 minutes), and every 10 minutes of exposure up to 180 minutes

  3. Heart Rate

    Measured with a 3-lead electrocardiogram

    Measured: At baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trial

  4. Skin Temperature

    Measured at 4 skin locations (chest, arm, thigh, and calf) using wireless iButtons affixed to the skin with surgical tape

    Measured: At baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trial

  5. Core Temperature

    rectal temperature measured with a pediatric grade thermistor probe

    Measured: At baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trial

  6. Whole-Body Sweat Rate

    Net difference in body mass (pre versus post) using a balance scale placed below the chair of the participant

    Measured: At baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trial

Secondary outcomes (2)
  1. Thermal Sensation

    visual analog scale

    Measured: At baseline (e.g. 0 minutes), and every 10 minutes for the 180 minute experimental trial

  2. Thermal comfort

    visual analog scale

    Measured: Assessed at baseline (e.g. 0 minutes), and every 10 minutes for the 180 minute experimental trial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2024
  2. Study start20 Jan 2024
  3. Primary completion30 Apr 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06584903
Sponsor's protocol ID
26897
Status last verified
Sep 2024
First submitted
3 Sep 2024
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All deidentified participant data supporting the findings of this study will be made freely available on the Open Science Framework Repository.

Questions about this trial

What is this clinical trial studying?

A study testing Temperature Ramp Protocol in people with Heat Exposure and Healthy, run by Lakehead University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood Pressure (time frame: At baseline (e.g. 0 minutes), and every 10 minutes of exposure up to 180 minutes). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in